22.09.2016 • NewsElaine BurridgeHuber

Huber Expands German Flame Retardant Plant

Just seven months after acquiring the former Martinswerk plant in Bergheim, Germany, the Fire Retardant Additives (FRA) business unit of Huber Engineering Materials, a division of J.M. Huber Corporation, is expanding capacity of precipitated alumina trihydrate. Output of the flame retardant will rise by 10% when the project is completed by the third quarter of 2017. The expansion follows a recently completed 20% hike in capacity for the material at Huber’s facility in Bauxite, Arkansas, USA.

Jerry Bertram, vice president and general manager of Huber’s FRA business, said the investment is the first in a series of expansions planned for Bergheim as it starts implementing its longer-term strategy. Managing director of Huber’s FRA European operations, Martin Schulting, added that the expansion is part of the company’s ongoing global growth plan and enables it to meeting increasing customer demand.

Huber Engineered Materials bought the Martinswerk business from Albemarle in February this year. It was its largest acquisition in more than 10 years and marked a series of investments to boost its flame retardants business. These acquisitions include the Safire nitrogen and phosphorus technology from Floridienne Group and its wholly-owned subsidiary Catena Additives in 2015; the specialty hydrates business of Almatis in 2012; and the Kemgard product line from Sherwin-Williams in 2010.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.